Newsbenzinga
Merck and Moderna Release Landmark Personalized Cancer Therapy Trial Success, Stocks Soar
· Published
Article summary
Merck and Moderna report positive Phase 3 results for their mRNA cancer therapy combined with Keytruda in melanoma patients.
An excerpt from the original article.
Comments —
Loading comments…